Results 41 to 50 of about 133,753 (204)

Trends in HIV pre-exposure prophylaxis use in eight Canadian provinces, 2014–2018

Canada Communicable Disease Report, 2021
Introduction: Canada has endorsed the Joint United National Programme on HIV and AIDS global targets to end the acquired immunodeficiency syndrome (AIDS) epidemic, including reducing new human immunodeficiency virus (HIV) infections to zero, by 2030 ...
Qiuying Yang, Chris Archibald
doaj   +1 more source

Implant Prophylaxis: The Next Best Practice Toward Asepsis in Spine Surgery. [PDF]

, 2018
Study designA literature review.ObjectivesAn evaluation of the contaminants prevalent on implants used for surgery and the aseptic methods being employed against them.MethodsPubMed was searched for articles published between 2000 and 2017 for studies ...
Agarwal, Aakash, Agarwal, Anand, Anand, Neel, Garfin, Steve R, Goel, Vijay K, Schultz, Christian, Wang, Jeffrey C   +6 more
core   +1 more source

The Democratic Biopolitics of PrEP [PDF]

, 2019
PrEP (Pre-Exposure Prophylaxis) is a relatively new drug-based HIV prevention technique and an important means to lower the HIV risk of gay men who are especially vulnerable to HIV.
Adam D Galinsky, Alain Giami, Amy L Hequembourg, Andrew D Forsyth, Barry D Adam, Beatriz Preciado, Bettina Schöne-Seifert, Carlos Novas, Catherine Mills, Christoph D Spinner, Christoph Menke, Cindy Patton, Daniel Grace, David M Halperin, David M Halperin, David M Halperin, Dawn K. Smith, Didier Fassin, Elizabeth F Closson, George Ayala, Giorgio Agamben, Giorgio Agamben, Heiner Meulemann, Hyman M Scott, Ingrid Young, Jaakko Ailio, Jaakko Ailio, Jaakko Ailio, Jae M Sevelius, Jared M Baeten, Jean-Michel Molina, Jeffrey Thomas Nealon, Jerome A Singh, Jessica E Haberer, Jessie L Juusola, Judith D Auerbach, Kane Race, Kane Race, Karen Schneider, Karsten Schubert, Kathleen R Page, Kimberly Koester, Latesha Elopre, Lauren V Wood, Mara Tognetti Bordogna, Marianne Pieper, Martin Holt, Martin Saar, Michael Hardt, Michael Hardt, Michel Foucault, Michel Foucault, Michel Foucault, Mingwang Shen, Mitchell Dean, Myron S Cohen, Myron S Cohen, Niels Doorn van, Nikolas Rose, Nikolas Rose, Nikolas Rose, Paul Rabinow, Paul Rabinow, Peter Langford, Robert M Grant, Roberto Esposito, Roberto Esposito, Roberto Esposito, Sarah K Calabrese, Sarit A. Golub, Shane P Collins, Sheena McCormack, Steven Epstein, Steven Epstein, Thea Cacchioni, Thomas Lemke, Thomas Lemke, Tim Dean, Tim Dean, Tim Dean, Tim Dean, Ulrich Bröckling, Ulrich Bröckling, Valentina Cambiano, Vinh-Kim Nguyen   +84 more
core   +5 more sources

The history and evolution of the clinical effectiveness of haemophilia type a treatment: a systematic review. [PDF]

, 2012
First evidence of cases of haemophilia dates from ancient Egypt, but it was when Queen Victoria from England in the 19th century transmitted this illness to her descendants, when it became known as the "royal disease".
A Aleem, A Farrugia, A Miners, A Mocroft, AL Dunn, BA Konkle, BL Evatt, BM Feldman, CA Lee, CL Poel Van der, Claudia P. Casas, D Dimichele, D Dimichele, E Berntorp, E Berntorp, E Santagostino, Hector E. Castro, J Astermark, J Goudemand, J Oldenburg, J Stachnik, J Tusell, J Wight, Juan David Rueda, K Porter, L Valentino, L Valentino, LM Aledort, M Carcao, M Carcao, M Depka Von, M Franchini, M Lloyd, M Makris, María Fernanda Briceño, MD Carcao, MV Ragni, P Petrini, PM Mannucci, PM Mannucci, R Prabhu, S Royal, SA Larsson, SC Darby, SC Gouw, T Wong, TL Chorba, VS Blanchette, WK Hoots   +48 more
core   +2 more sources

Longitudinal cohort of HIV-negative transgender women of colour in New York City: protocol for the TURNNT ('Trying to Understand Relationships, Networks and Neighbourhoods among Transgender women of colour') study. [PDF]

, 2020
IntroductionIn the USA, transgender women are among the most vulnerable to HIV. In particular, transgender women of colour face high rates of infection and low uptake of important HIV prevention tools, including pre-exposure prophylaxis (PrEP).
Bluebond-Langner, Rachel, Callander, Denton, Chaix, Basile, Doroshow, Ceyenne, Duncan, Dustin T, Garofalo, Robert, Herrera, Cristina, Kawachi, Ichiro, Love, Gia, Poteat, Tonia, Radix, Asa, Ransome, Yusuf, Regan, Seann D, Reisner, Sari L, Scheinmann, Roberta, Schneider, John A, Sevelius, Jae, Smith, Jordyn, St James, Kiara, Toussaint, Nala, Watson, Kim   +20 more
core   +4 more sources

Prescribing pre-exposure prophylaxis in general practice

Australian Journal of General Practice, 2021
Pre-exposure prophylaxis (PrEP) is a highly effective method of human immunodeficiency virus (HIV) prevention available to prescribe on the Pharmaceutical Benefits Scheme general schedule.The aim of this article is to provide information and guidance to general practitioners (GPs) and other healthcare providers on providing PrEP, and to discuss ...
Osama, Bhatti, Darren, So, Muhammad Abdullah, Zahid, Vincent J, Cornelisse   +3 more
openaire   +3 more sources

Factors associated with university students’ knowledge about HIV and preand post-exposure prophylaxis [PDF]

Revista Brasileira de Enfermagem
Objectives: to analyze the factors associated with university students’ knowledge about HIV and preand post-exposure prophylaxis. Methods: a cross-sectional study was conducted with 503 university students from a southern state in Brazil; data were ...
Ana Luísa Serrano Lima, Heitor Hortensi Sesnik, Lucas Vinícius de Lima, Gabriel Pavinati, Maria de Fátima Garcia Lopes Merino, Marcelle Paiano, Nelly Lopes de Moraes Gil, Gabriela Tavares Magnabosco   +7 more
doaj   +1 more source

Pre-exposure prophylaxis for the prevention of HIV infection: a new prevention paradigm? [PDF]

Farmacia Hospitalaria, 2016
Pre-exposure prophylaxis” (PrEP) has been recently developed as a prevention strategy which involves the administration of drugs to non-infected individuals who present high exposure or susceptibility to HIV.
Javier Sánchez-Rubio Ferrández, José Manuel Martínez Sesmero   +1 more
doaj   +1 more source

Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women [PDF]

, 2011
The early closure of a clinical trial assessing the effectiveness of oral antiretroviral pre-exposure prophylaxis (PrEP) in women, FEM-PrEP, is a substantial setback for HIV prevention.
Abdool Karim, Angela DM Kashuba, Dumond, Grant, Karim, Lise Werner, Quarraisha Abdool Karim, Salim S Abdool Karim   +7 more
core   +2 more sources

Depression and Oral FTC/TDF Pre-exposure Prophylaxis (PrEP) Among Men and Transgender Women Who Have Sex With Men (MSM/TGW). [PDF]

, 2016
We conducted a longitudinal and cross-sectional analysis of depressive symptomology in iPrEx, a randomized, placebo-controlled trial of daily, oral FTC/TDF HIV pre-exposure prophylaxis (PrEP) in men and transgender women who have sex with men. Depression-
Amico, K Rivet, Avelino-Silva, Vivian I, Burns, David, Chodacki, Piotr, Defechereux, Patricia A, Fernandez, Telmo, Glidden, David V, Grant, Robert M, iPrEx Study Team, Liu, Albert Y, Mayer, Kenneth H, McMahan, Vanessa M, Mehrotra, Megha, Vargas, Lorena   +13 more
core   +1 more source